Mass Spectrometry Platform (IMAGE)

Charité - Universitätsmedizin Berlin

Mass Spectrometry Platform

Caption

Researchers used mass spectrometry to identify biomarker profiles which can be used to classify disease severity in patients with COVID-19. These biomarker profiles could also be used to predict disease progression.

Credit

Photo: Arne Sattler/Charité

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.